What is EBUS-TBNA?
EBUS-TBNA stands for endobronchial ultrasound guided transbronchial needle aspiration. A specialised bronchoscope with an ultrasound probe at its tip is passed into the airways. The ultrasound looks through the airway wall at the structures beyond it, so lymph nodes, masses and blood vessels that cannot be seen with an ordinary bronchoscope become visible. A fine needle is then advanced through the airway wall into the target under real-time ultrasound vision, and cells or tissue are aspirated for laboratory analysis.
Before this technology, sampling lymph nodes in the centre of the chest usually required mediastinoscopy, a surgical procedure performed under general anaesthesia through an incision at the base of the neck, with an overnight stay. EBUS-TBNA achieves comparable diagnostic accuracy for most stations as a day-care procedure, with no incision, and it can be repeated when necessary. Colour Doppler on the ultrasound image identifies blood vessels so that they can be avoided, which makes the technique both accurate and safe.
Symptoms and findings that lead to EBUS-TBNA
Patients are usually referred after a CT or PET-CT rather than because of a single symptom, but the clinical picture that leads there commonly includes:
- Enlarged mediastinal or hilar lymph nodes found on CT or showing uptake on PET-CT.
- A suspected or confirmed lung cancer that needs accurate staging before deciding between surgery, radiotherapy and systemic treatment.
- Persistent cough, chest discomfort, hoarseness or breathlessness with mediastinal nodal enlargement.
- Fever, weight loss and night sweats with enlarged chest nodes, where tuberculosis and lymphoma must be separated.
- Suspected sarcoidosis, particularly when the nodes are enlarged on both sides.
- A known cancer elsewhere in the body with new chest nodes, to determine whether the disease has spread.
- A central lung mass sitting adjacent to a large airway that can be sampled with the needle.
What EBUS-TBNA can diagnose
| Condition | Role of EBUS-TBNA |
|---|---|
| Lung cancer staging | Confirms or excludes nodal spread station by station, which decides operability and treatment intent |
| Lung cancer diagnosis | Provides tissue for cell type, and adequate material for EGFR, ALK, ROS1 and other molecular tests plus PD-L1 |
| Tuberculous lymphadenitis | Samples for GeneXpert, mycobacterial culture and histology showing necrotising granulomas |
| Sarcoidosis | Non-necrotising granulomas with negative microbiology, avoiding surgical biopsy in most patients with suspected granulomatous lung disease |
| Lymphoma | Cell samples for flow cytometry, though a larger surgical biopsy is sometimes still required |
| Metastatic disease from other organs | Confirms spread to mediastinal nodes and helps identify the primary site |
| Cysts and vascular structures | Ultrasound differentiates them so that they are not punctured inadvertently |
In this region the separation of tuberculosis from sarcoidosis is one of the most valuable uses of the technique, because both cause bilateral hilar lymph node enlargement and granulomas, yet one requires antimicrobial treatment and the other may require corticosteroids. Sending the aspirate for both microbiology and pathology is essential.
How the procedure is performed
Preparation
Fasting for about six hours is required. Recent CT or PET-CT images are reviewed to plan which nodal stations to sample and in which order. Blood counts and clotting are checked, antiplatelet and anticoagulant drugs are adjusted in consultation with the prescriber, and diabetes medication is modified for the fasting period. Existing conditions such as asthma, heart disease and previous anaesthetic problems are discussed beforehand.
During the procedure
EBUS is performed under deep sedation or general anaesthesia, with continuous monitoring of oxygen, heart rhythm and blood pressure. The bronchoscope is passed through the mouth, and each accessible nodal station is examined with ultrasound. Doppler confirms that no vessel lies in the needle path, and the needle is then passed into the node several times while suction is applied. Multiple passes are taken from each station, and in cancer staging the sampling deliberately proceeds from the stations furthest from the tumour towards the nearest, so that contamination does not falsely upstage the disease. Where available, rapid on-site cytological evaluation confirms during the procedure that adequate material has been obtained. A typical procedure takes thirty to sixty minutes.
Recovery
Patients are observed until fully awake, take nothing by mouth for about two hours, and usually go home the same day. A sore throat, mild cough and small blood-streaked sputum for a day or so are common. Someone should accompany the patient home, and driving is avoided for the rest of the day.
What happens after the result
The findings determine the next step directly. Cancer confined to the lung with negative nodes may proceed to surgery with curative intent. Nodal involvement generally shifts treatment towards combined chemotherapy, radiotherapy or immunotherapy, and molecular results from the same sample may open the door to targeted oral therapy. A diagnosis of tuberculous lymphadenitis leads to a full anti-tuberculosis regimen guided by drug susceptibility. Sarcoidosis is treated according to symptoms and organ involvement, often with observation alone in mild disease. If the aspirate is non-diagnostic despite a strong clinical suspicion, options include repeat EBUS, mediastinoscopy, or surgical biopsy, decided in a multidisciplinary discussion.
Risks
EBUS-TBNA has an excellent safety record. Minor bleeding at the puncture site, sore throat, cough and transient fever are the usual events. Uncommon complications include significant bleeding, infection or abscess formation in a sampled node, mediastinitis, pneumothorax and pneumomediastinum, and reactions related to sedation. Serious complications occur in well under one per cent of procedures in experienced centres. The alternative of surgical mediastinoscopy carries a higher overall risk and requires admission.
Frequently asked questions
How is EBUS different from ordinary bronchoscopy?
A standard bronchoscope only sees the inside surface of the airway. EBUS adds an ultrasound probe that sees through the airway wall, so structures such as lymph nodes and masses outside the airway can be located precisely and sampled with a needle under real-time vision.
Is EBUS-TBNA better than surgical mediastinoscopy?
For most mediastinal stations it provides comparable accuracy without an incision, without a hospital stay, and with fewer complications, so it is now the first-line test. Mediastinoscopy remains useful when EBUS is non-diagnostic or when larger tissue volume is required, for example in some lymphomas.
Is the procedure painful?
No. It is performed under deep sedation or general anaesthesia, and patients do not feel the needle passes. Mild throat discomfort and cough afterwards are the usual experience.
Can EBUS confirm whether a lung nodule is cancer?
EBUS-TBNA is designed for lymph nodes and masses adjacent to the central airways. Small nodules in the outer part of the lung are approached differently, using radial EBUS with a guide sheath, navigation bronchoscopy or a CT-guided needle biopsy through the chest wall.
Will one sitting be enough for a diagnosis?
In the great majority of patients, yes, particularly when several passes are taken from each station and on-site cytology confirms adequacy. A small proportion need a repeat procedure or an alternative biopsy method.
Is enough tissue obtained for molecular testing?
Yes. With adequate passes and correct sample handling, EBUS aspirates routinely support cell block preparation, immunohistochemistry, molecular testing and PD-L1 assessment, which are essential for choosing targeted therapy or immunotherapy in lung cancer.
How soon will I get the report?
Preliminary cytology may be available within one to two days and formal histopathology within three to seven days. GeneXpert results for tuberculosis are usually available in a day, while mycobacterial culture and molecular oncology testing take longer.
Related conditions and procedures
Consult Dr. Gogineni Ratnakara Rao
Apollo Hospitals, Financial District: Monday to Saturday, 8:30 AM to 5:00 PM. Anything in Lung Clinic, Chanda Nagar: Monday to Saturday (Thursday closed), 6:00 PM to 9:00 PM.